Finzati - Logo
PHG logo

Koninklijke Philips N.V.

PHG • Medical - Devices
$25.89
▼ -0.16 (-0.61%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$25.08B
Growth
-0.2%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive free cash flow · 0.93Consistent free cash flow · 4/5Manageable debt level · 0.74Healthy liquidity · 1.32Negative growth trend
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$25.89
Change-0.61%
Shares Out968.53M
Market Cap$25.08B
52W Range21.95 - 33.44
Beta0.92
P/E37.13
P/S5.74
P/B1.97
P/FCF191.85
EV/Sales7.19
EV/EBITDA52.17

Investment DNA

How strong this company looks for long-term investors

55
out of 100
Business Quality
Margins, moat, returns
45/100
Financial Strength
Debt, cash, stability
65/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
75/100
Why this score▼
Positive free cash flow · 0.93Consistent free cash flow · 4/5Manageable debt level · 0.74Healthy liquidity · 1.32Negative growth trend

Analyst view

Analyst sentiment and price target

PHG
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
68/100
Neutral
Bullish
8
Hold
14
Bearish
0

Company Overview

IPO: 3/17/1980
Industry: Medical - Devices
P/B i: 1.97
Debt / Equity i: 0.74
Operating Margin: 7.98%
Net Margin: 5.02%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 0.74
Current Ratio: 1.32
Quick Ratio: 0.94
Status: Good
🧾

No insider activity

No recent insider transactions available.